1. Home
  2. EVH vs ASMB Comparison

EVH vs ASMB Comparison

Compare EVH & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolent Health Inc

EVH

Evolent Health Inc

HOLD

Current Price

$3.99

Market Cap

468.7M

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$30.81

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVH
ASMB
Founded
2011
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
468.7M
553.6M
IPO Year
2015
2010

Fundamental Metrics

Financial Performance
Metric
EVH
ASMB
Price
$3.99
$30.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
6
Target Price
$12.25
$43.40
AVG Volume (30 Days)
2.9M
150.8K
Earning Date
02-19-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,054,052,000.00
$37,191,000.00
Revenue This Year
N/A
$33.33
Revenue Next Year
$27.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
31.30
52 Week Low
$3.50
$7.75
52 Week High
$12.98
$39.71

Technical Indicators

Market Signals
Indicator
EVH
ASMB
Relative Strength Index (RSI) 39.58 39.55
Support Level $3.86 $31.73
Resistance Level $4.07 $34.69
Average True Range (ATR) 0.17 2.07
MACD 0.06 -0.36
Stochastic Oscillator 37.63 2.50

Price Performance

Historical Comparison
EVH
ASMB

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: